Winton Group LTD Exact Sciences Corp Transaction History

Winton Group LTD

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$56.27 - $73.77 $1.26 Million - $1.65 Million	22,340 New	22,340 $1.54 Million
Q2 2021 Aug 10, 2021	SELL	$93.66 - $139.27 $314,135 - $467,111	-3,354 Closed	0 $0
Q1 2021 Jul 21, 2021	SELL	$116.57 - $155.01 $71,340 - $94,866	-612 Reduced 15.43%	3,354 $442,000
Q4 2020 Feb 12, 2021	BUY	$99.61 - $142.12 $395,053 - $563,647	3,966 New	3,966 $525,000
Q3 2020 Oct 30, 2020	SELL	$72.92 - $102.01 $357,453 - $500,053	-4,902 Closed	0 $0
Q2 2020 Aug 05, 2020	SELL	$55.75 - $92.75 $1.06 Million - $1.77 Million	-19,072 Reduced 79.55%	4,902 $426,000
Q1 2020 May 11, 2020	BUY	$37.9 - $104.44 $812,424 - $2.24 Million	21,436 Added 844.6%	23,974 $1.39 Million
Q4 2019 Feb 13, 2020	SELL	$77.66 - $99.74 $55,449 - $71,214	-714 Reduced 21.96%	2,538 $235,000
Q3 2019 Nov 08, 2019	SELL	$90.37 - $122.49 $161,943 - $219,502	-1,792 Reduced 35.53%	3,252 $294,000
Q2 2019 Jul 08, 2019	SELL	$89.51 - $118.04 $159,954 - $210,937	-1,787 Reduced 26.16%	5,044 $595,000
Q1 2019 May 13, 2019	SELL	$61.98 - $96.5 $296,698 - $461,945	-4,787 Reduced 41.2%	6,831 $592,000
Q4 2018 Feb 05, 2019	BUY	$56.04 - $82.66 $299,141 - $441,239	5,338 Added 85.0%	11,618 $733,000
Q3 2018 Nov 02, 2018	SELL	$48.29 - $80.6 $46,793 - $78,101	-969 Reduced 13.37%	6,280 $0
Q2 2018 Aug 20, 2018	SELL	$37.84 - $69.96 $351,382 - $649,648	-9,286 Reduced 56.16%	7,249 $0
Q1 2018 May 21, 2018	BUY	$39.82 - $57.53 $658,423 - $951,258	16,535 New	16,535 $0

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.